William N. Kelly, Pharm. D., FISPE

Consultant and Expert

Medication Safety, Pharmacoepidemiology,
Expert Witnessing, and Pharmacy Practice

home
services
qualifications
publications
books
contact

 

(770) 855-5571

wnkelly@umich.edu

 

 


Recent Publications

Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez SB, Goldsmith DI, Huang KA, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, and Wise RP. Guidelines for submitting adverse event reports for publication. Drug Safety. 2007;30(5):367-373.

Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez SB, Goldsmith DI, Huang KA, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, and Wise RP. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiology and Drug Safety. 2007;16:581-587.

Kelly WN. Pharmacy: What It Is and How It Works. CRC Publishing Company, Boca Raton, Florida. 2nd Edition, 2002, 2007.

Kelly WN. Prescribed Medication and the Public Health: Laying the Foundation for Risk Reduction. Haworth Press, Binghamton, NY. 2006.

Kelly WN. Compelling Features of a Safe Medication Use System. American Journal of Health-System Pharmacists. 2006;63:1461-6

Kelly WN.  The Role of Pharmacoepidemiology in Drug Injury and Expert Testimony. Chapter 11 in Drug Injury: Liability, Analysis and Prevention. Second Edition. Edited by James T. O’Donnell. Lawyers and Judges Publishing Company. Tucson, AZ. 2005.

Al-Tajir G and Kelly WN.  The Epidemiology, Methods of Detecting, and Preventing of Adverse Drug Events at Al Qassimi Hospital.  Annals of Pharmacotherapy. 2005;39:1169-1174.

Kelly WN. Medication Errors: Lessons Learned and Actions Needed. Professional Safety. 2004;49(7):35-41. 

Voiles KM and Kelly WN. Potential Interactions Between Oral Contraceptives and Other Medications and Natural Substances. U.S. Pharmacist. 2004;29(1).

Steele DR and Kelly WN. Documenting Errors Benefits Patients, Pharmacies. Drug Topics. 2004:January 26;66, 71.

Housley S, and Kelly WN. Drug Interaction Monitoring: Good, Bad, and Ugly. Drug Topics. 2003:September 1; 41-42.

Kelly WN. The quality of published adverse drug event reports. Annals of Pharmacotherapy. 2003;37(12):1774-1778.